Testosterone Plus Anastrozole Pellets for Hypogonadism Treatment

Contraindications and Precautions

• The American Society of Clinical Oncology recommends that anastrozole should not be prescribed to premenopausal women due to potential adverse effects 1, 2
• Patients with severe osteoporosis (T-score < -4 or more than two vertebral fractures) should not receive anastrozole due to increased risk of bone fractures 1, 2
• A baseline bone mineral density measurement is mandatory before initiating anastrozole to assess the risk of osteoporosis 1, 2, 3

Monitoring and Maintenance

• The Endocrine Society recommends monitoring testosterone levels at 2-3 months after initiation or dose changes, then every 6-12 months once stable 4
• Target mid-normal testosterone range (500-600 ng/dL) to minimize the risk of adverse effects 4
• Bone density monitoring is essential in patients on anastrozole to prevent accelerated bone loss 1, 2, 3

Side Effects and Management

• Joint stiffness and arthralgias are very common side effects of anastrozole, and patients should be counseled about this potential risk 1, 2
• Vasomotor symptoms (hot flashes) and hypertension are also common side effects of anastrozole 1, 2
• Accelerated bone loss is a potential side effect of anastrozole, and calcium and vitamin D supplementation is mandatory to prevent this 1, 2, 5, 3

Bone Protection Strategy

• The National Comprehensive Cancer Network recommends calcium and vitamin D supplementation for all patients receiving testosterone pellets with anastrozole to prevent bone loss 1, 2, 5, 3
• Regular weight-bearing exercise is also essential to maintain bone density 1, 2, 3
• Consider bisphosphonates or RANKL inhibitors in patients with moderate bone loss to prevent further bone degradation 1, 3